Amgen, Inc. (AMGN)
432.42
-4.57
(-1.05%)
USD |
NASDAQ |
Aug 28, 16:00
431.99
-0.43
(-0.10%)
After-Hours: 20:00
Amgen Cash and Short Term Investments (Quarterly) : 13.99B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.99B |
| March 31, 2026 | 12.04B |
| December 31, 2025 | 9.129B |
| September 30, 2025 | 9.445B |
| June 30, 2025 | 8.028B |
| March 31, 2025 | 8.81B |
| December 31, 2024 | 11.97B |
| September 30, 2024 | 9.011B |
| June 30, 2024 | 9.301B |
| March 31, 2024 | 9.708B |
| December 31, 2023 | 10.94B |
| September 30, 2023 | 34.74B |
| June 30, 2023 | 34.25B |
| March 31, 2023 | 31.56B |
| December 31, 2022 | 9.305B |
| September 30, 2022 | 11.48B |
| June 30, 2022 | 7.183B |
| March 31, 2022 | 6.544B |
| December 31, 2021 | 8.037B |
| September 30, 2021 | 12.92B |
| June 30, 2021 | 8.082B |
| March 31, 2021 | 10.57B |
| December 31, 2020 | 10.65B |
| September 30, 2020 | 12.36B |
| June 30, 2020 | 11.42B |
| Date | Value |
|---|---|
| March 31, 2020 | 8.012B |
| December 31, 2019 | 8.911B |
| September 30, 2019 | 20.85B |
| June 30, 2019 | 21.76B |
| March 31, 2019 | 26.30B |
| December 31, 2018 | 29.30B |
| September 30, 2018 | 29.92B |
| June 30, 2018 | 29.40B |
| March 31, 2018 | 32.17B |
| December 31, 2017 | 41.68B |
| September 30, 2017 | 41.35B |
| June 30, 2017 | 39.23B |
| March 31, 2017 | 38.40B |
| December 31, 2016 | 38.08B |
| September 30, 2016 | 37.98B |
| June 30, 2016 | 35.03B |
| March 31, 2016 | 34.74B |
| December 31, 2015 | 31.38B |
| September 30, 2015 | 31.12B |
| June 30, 2015 | 29.99B |
| March 31, 2015 | 27.12B |
| December 31, 2014 | 27.03B |
| September 30, 2014 | 28.08B |
| June 30, 2014 | 26.19B |
| March 31, 2014 | 19.80B |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 4.882B |
| Regeneron Pharmaceuticals, Inc. | 8.005B |
| AbbVie, Inc. | 6.569B |
| Biogen, Inc. | 1.285B |
| Vertex Pharmaceuticals, Inc. | 7.863B |